Progress in Cannabis Regulation: New Law (CanG) Charts the Course

A significant milestone has been achieved today in the realm of cannabis as the cabinet has approved the “Draft Law on the Controlled Use of Cannabis and Amendments to Other Regulations” (CanG). This groundbreaking draft, based on an innovative two-pillar approach, is set to reshape the industry fundamentally. The reformation aims to regulate cannabis use while ensuring the protection of children and adolescents.

The CanG law includes provisions allowing adult citizens to cultivate up to three cannabis plants for personal use. Additionally, the possession of up to 25 grams of cannabis is decriminalized. Simultaneously, an advertising and sponsorship ban on consumption cannabis and cultivation associations is introduced to bolster youth protection.

Federal Minister of Health, Prof. Karl Lauterbach, emphasized, “The Cannabis Law marks an urgently needed shift in drug policy. Our goal is to curb the black market and decrease consumption rates. Despite legalization, we remain aware that cannabis can be harmful, especially to developing brains. Hence, we are launching an awareness campaign today to educate young people about the risks.”

Federal Minister of Agriculture, Cem Özdemir, added, “This law strikes a balance between individual freedom and public welfare. It grants adults legal access to cannabis while strengthening youth protection. We create secure, controlled, and legal avenues for cannabis consumption, while focusing on prevention and health protection.”

Natural Pharma, known as one of the trailblazers in product quality and transparency within the cannabis industry, welcomes this progressive legislation and is prepared to embrace the ensuing opportunities and challenges. The company remains committed to providing high-quality and safe cannabis products, while upholding the highest standards of compliance and consumer protection.

Source: https://www.bundesgesundheitsministerium.de/presse/pressemitteilungen/bundeskabinett-beschliesst-cannabisgesetz-pm-16-08-23.html

PR-Contact for Natural Pharma

Dr. Daniel König
+49 (0) 2173 940 95 91
press(ät)natpha.com

Natural Pharma Offers Premium Services for German Pharmacies

Natural Pharma Resource (Natural Pharma) GmbH, is delighted to introduce its premium services specifically tailored for German pharmacies. With a strong focus on excellence, Natural Pharma aims to assist German pharmacies in establishing a robust and effective online presence.

As the cannabis industry continues to evolve, pharmacies play a crucial role in providing patients with access to high-quality cannabis products. However, many pharmacies encounter challenges in effectively showcasing their offerings online. Natural Pharma has recognized these needs and developed a range of exceptional services to address them.

Leveraging its extensive expertise in the distribution of cannabis products, Natural Pharma now extends its services to support pharmacies in creating secure and informative websites. Through IT services that encompass website design and development, Natural Pharma ensures that pharmacies can present their product availability clearly and attractively.

A standout feature of Natural Pharma’s premium service is the seamless integration of a dedicated availability table for cannabis flowers, extracts, and applications. This secure table is accessible through a password-protected area, enabling patients and treating physicians to log in securely using DocCheck credentials. This ensures accurate recording of the correct and available medication on the prescription.

Natural Pharma firmly believes that a robust online presence is essential for German pharmacies to expand their reach and attract international patients. With their premium service offerings, they aspire to be the preferred partner for German pharmacies seeking a comprehensive solution for their online needs.

German pharmacies and healthcare professionals interested in learning more about Natural Pharma’s premium services can reach out to them via email at apotheken@natpha.de or by phone, Monday to Friday, between 10:00 and 18:00.

PR-Contact for Natural Pharma

Dr. Daniel König
+49 (0) 2173 940 95 91
press(ät)natpha.com

Natural Pharma continues its successful start to the new year by expanding and deepening its partnerships to offer patients additional therapy options.

In January 2023, Natural Pharma successfully expanded its product range and now offers 400g bags of Bedrocan. The company is pleased to have already received Bedrocan pre-orders until July 2023, but unfortunately the product is sold out until then. Unfortunately, there are also certain medications that are not permanently available, which can lead to a discontinuation of therapy. However, Bedrocan will continue to be supplied by other German wholesalers to ensure that the therapy option remains continuously available for patients.

At Natural Pharma, they are proud to contribute to ensuring that patients receive continuous and reliable care. The goal is to continuously offer new, traceable, and permanently available therapy options for patients. In collaboration with our partner Beacon Medical Germany, a German subsidiary of the Canadian company VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF), Natural Pharma is achieving these goals and ensuring that the highest quality standards are met. Currently, Beacon Medical Germany is registering new medications with the IFA. By early Q3/23, additional EU-GMP products will be introduced to the market to enable further therapy options for patients.

In the future, Natural Pharma will continue to expand its therapy options by gaining additional partners and receiving medications from its partner Beacon Medical. The products from Beacon Medical Germany are exclusively grown and produced indoors at ABcann Medicinals Inc. in Napanee, Ontario, Canada. The products meet the highest quality standards, including GACP and EU-GMP at a single location. Natural Pharma is proud to offer better support to treating physicians, suffering patients, and distributing pharmacies by providing additional therapy options to enable better quality of life and sustained therapy for patients.

Natural Pharma remains committed to understanding the needs of patients. With the introduction of new products and the expansion of therapy options through partnerships such as Beacon Medical, it is on the right track to achieve this goal.

PR-Contact for Natural Pharma

Dr. Daniel König
+49 (0) 2173 940 95 91
press(ät)natpha.com